scispace - formally typeset
S

Sigrun Hope

Researcher at Oslo University Hospital

Publications -  49
Citations -  2423

Sigrun Hope is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Schizophrenia & Bipolar disorder. The author has an hindex of 20, co-authored 46 publications receiving 1704 citations. Previous affiliations of Sigrun Hope include University of Oslo.

Papers
More filters
Journal ArticleDOI

Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders

Phil Lee, +606 more
- 12 Dec 2019 - 
TL;DR: Genetic influences on psychiatric disorders transcend diagnostic boundaries, suggesting substantial pleiotropy of contributing loci within genes that show heightened expression in the brain throughout the lifespan, beginning prenatally in the second trimester, and play prominent roles in neurodevelopmental processes.
Journal ArticleDOI

Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia

TL;DR: The current associations between inflammatory markers and affective symptomatology in BP and not SCZ suggest that immune related mechanisms are associated with core psychopathology of BP.
Journal ArticleDOI

Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor.

TL;DR: In this article, the authors examined markers representing different inflammatory pathways, and the aim was to investigate whether the levels of inflammatory parameters in a representative sample of bipolar disorder and schizophrenia are elevated compared to healthy controls.
Journal ArticleDOI

Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder.

TL;DR: It is found that inflammatory markers, particularly IL-1Ra and sTNF-R1 are associated with both general disease severity and psychotic features, which supports a role of immune activation in the core pathological mechanisms of severe mental disorders.
Posted ContentDOI

Common risk variants identified in autism spectrum disorder

Jakob Grove, +76 more
- 25 Nov 2017 - 
TL;DR: It is established that GWAS performed at scale will be much more productive in the near term in ASD, just as it has been in a broad range of important psychiatric and diverse medical phenotypes.